missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Phospho-EGFR (Ser967) Polyclonal Antibody

Phospho-EGFR (Ser967) Polyclonal Antibody
Brand: Invitrogen PA5143693
This item is not returnable.
View return policy
Description
Phospho-EGFR (Ser967) Polyclonal Antibody for Western Blot, ICC/IF
Specifications
| Phospho-EGFR (Ser967) | |
| Polyclonal | |
| Unconjugated | |
| EGFR | |
| 2.7.10.1; 9030024J15Rik; AI552599; avian erythroblastic leukemia viral (v-erbB) oncogene homolog; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; EC 2.7.10.1; egf receptor; Egfr; EGFR-related peptide; epidermal growth factor receptor; epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); Epidermal growth factor receptor formerly avian erythroblastic leukemia viral (v-erbB) oncogene homolog (Erbb1); epidermal growth factor receptor, formerly avian erythroblastic leukemia viral (v-erbB) oncogene homolog (Erbb1); ERBB; ERBB1; ErbB-1; erb-b2 receptor tyrosine kinase 1; Errb1; Errp; HER1; kinase EGFR; mENA; NISBD2; Oncogene ERBB; PIG61; Proto-oncogene c-ErbB-1; receptor tyrosine-protein kinase erbB-1; Urogastrone; wa2; wa-2; Wa5; waved 2 | |
| Rabbit | |
| Antigen Affinity Chromatography | |
| RUO | |
| 13649, 1956, 24329 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 0.5 mg/mL | |
| PBS with 1mg/mL BSA, 50% glycerol and 0.05% sodium azide | |
| P00533, Q01279 | |
| EGFR | |
| Phospho-EGFR (Ser-967) synthetic peptide (coupled to KLH) corresponding to amino acid residues surrounding serine 967 of human EGFR (ErbB-1). This human EGFR sequence has high homology to rat and mouse EGFR, and low homology to other ErbB family members. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction